SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-046088
Filing Date
2023-08-16
Accepted
2023-08-16 17:58:06
Documents
2
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1658
2 EX-24 DOCUMENT attachment1.htm EX-24 2164
  Complete submission text file 0001209191-23-046088.txt   5435
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRACTA THERAPEUTICS, INC. 2533 S. COAST HWY 101, SUITE 210 CARDIFF CA 92007
Business Address
Cohen Darrel P. (Reporting) CIK: 0001989794 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 231179320